ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Management of limited stage DLBCL with bulky disease

Management of limited stage DLBCL with bulky disease
This algorithm should be used together with related UpToDate topics for diagnosis, staging, management, and follow-up of DLBCL. We consider bulky disease to be a tumor mass ≥10 cm in diameter; PET-negative (Deauville 1-3); and PET-positive (Deauville 4-5).
DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophsophamide, vincristine, doxorubicin, prednisone; PET6: positron emission tomography after R-CHOP for 6 cycles; ISRT: involved site radiation therapy; Gy: gray; FDG: fluorodeoxyglucose.
Graphic 127164 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟